# Kotak Private Equity

> Kotak Private Equity is a VC fund backing Health Care, Life Science and Biotechnology. See 9 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 9
- Last investment: Dec 2023
- Lead investor: 22%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/kotak-private-equity/about/

Kotak Private Equity is a financial services company.

## Round sizes

| Stage | Round size |
| --- | --- |
| Private Equity | $4.3M–$14M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 44% |
| Life Science | 2 | 22% |
| Biotechnology | 2 | 22% |
| Fitness | 1 | 11% |
| Payments | 1 | 11% |

19 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 22% |
| Private Equity | 2 | 22% |
| Series A | 1 | 11% |
| Series B | 1 | 11% |
| Series F | 1 | 11% |

6 stages tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Monitra Healthcare | Monitra Healthcare is a Hyderabad based med-tech company developing solutions that capture cardiac events anytime anywhere. Our products detect cardiac arrhythmias and cardiovascular disease at real-time for pre-emptive treatments. Cardiac monitoring is widely used to identify heart disease, to monitor cardiac activity before and after surgery andother cardiac procedures, and to assess the effects of therapeutic drugs on cardiac activity. The Company’s vision is to dramatically reduce the effects of heart disease by making monitoring and pre-emptive cardiac care a seamless part of everyday life. | $1.5M | Seed | Dec 17, 2023 |  |
| Zaggle | Zaggle is an award-winning digital payments, cashback and analytics company. The company help corporates and individuals enjoy gifts and experiences across multiple channels everyday; in the form of employee rewards and recognition, channel partner incentives, employee benefits, online shopping cash back and restaurant cash back. | $30.6M |  | Sep 13, 2023 |  |
| Eyestem | Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell therapy and ophthalmology experts. It also boasts a world class advisory board and we have built collaborations with pioneers and leaders in the space. Our long-term vision is to create a global and scalable cell therapy platform to treatincurable diseases. We are developing a cell therapy platform to produce consistent, quality products over the next few years, concentrating on in vitro efficacy and safety. | $6.4M | Series A | Aug 08, 2022 |  |
| Licious | Licious is a path breaking concept in the Indian Food industry; aimed at solving the perennially existing problem of finding safe, delectable, trustworthy fresh meat in India. The company builds a world-class enterprise that's bound to upgrade the way the company procures, sells, buys, and consumes meat in India. | $149.8M | Series F | Mar 14, 2022 |  |
| Ahammune Biosciences | Ahammune Biosciences is an innovation-led drug discovery company started in 2016 which focuses on developing new treatment options for immune mediated diseases of the skin. Our current program is on the depigmenting disorder, Vitiligo. |  | Seed | Apr 26, 2021 |  |
| Healthians | Healthians is an online platform that provides health test home service. It is equipped with a technology-driven healthcare matrix, an army of trained full-time phlebotomists and precision-driven alliance with labs.The company is driven by a mission is to provide affordable, accurate, and reliable test results to all. Healthians was founded in2014 and is headquartered in Gurgaon, Haryana. |  | Series B | Nov 18, 2019 |  |
| Dynaspede | Dynaspede is a manufacture of electro-mechanical components and sub-systems for the mechatronics business sector. | $4.3M | Private Equity | Mar 01, 2008 |  |
| SIRO Clinpharm | SIRO Clinpharm is a clinical research organisation. | $14.3M | Private Equity | Mar 01, 2007 |  |
| Dynaspede | Dynaspede is a manufacture of electro-mechanical components and sub-systems for the mechatronics business sector. | $4.3M | Private Equity | Mar 01, 2006 |  |

9 of 9 investments shown.

## Co-investors
- [SIDBI Venture Capital](https://shizune.co/investors/profile/sidbi-venture-capital) — VC Fund, 2 deals together
- [3i Group](https://shizune.co/investors/profile/3i-group) — VC Fund, 1 deal together
- [Abakkus](https://shizune.co/investors/profile/abakkus) — VC Fund, 1 deal together
- [Alkem Laboratories](https://shizune.co/investors/profile/alkem-laboratories) — VC Fund, 1 deal together
- [Amansa Capital](https://shizune.co/investors/profile/amansa-holdings) — VC Fund, 1 deal together
- [Ananta Capital](https://shizune.co/investors/profile/ananta-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Titan Capital](https://shizune.co/investors/profile/titan-capital) — VC Fund
- [Inflection Point Ventures](https://shizune.co/investors/profile/inflection-point-ventures-d275) — VC Fund
- [Blume Ventures](https://shizune.co/investors/profile/blume-ventures) — VC Fund

## Featured in investor lists
- [Biotech VC Funds in India](https://shizune.co/investors/biotech-vc-funds-india)
- [Biotechnology Investors in India](https://shizune.co/investors/biotechnology-investors-india)
- [Biotechnology VC Funds in India](https://shizune.co/investors/biotechnology-vc-funds-india)
- [Biotech Investors in India](https://shizune.co/investors/biotech-investors-india)
- [Life Science Investors in India](https://shizune.co/investors/life-science-investors-india)
- [Life Science VC Funds in India](https://shizune.co/investors/life-science-vc-funds-india)

## FAQ

### What does Kotak Private Equity invest in?

Kotak Private Equity invests primarily in Health Care, Life Science and Biotechnology startups, most often at Seed and Private Equity stage. Most of the 9 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Kotak Private Equity's check size?

Kotak Private Equity typically joins rounds of $4.3M–$14M at Private Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Kotak Private Equity participates in.

### When did Kotak Private Equity last invest?

The most recent investment recorded for Kotak Private Equity closed in Dec 2023. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co